cbdMD (YCBD) 10-Q2023 Q2 Quarterly report

Filed: 15 May 23, 4:26pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: absent, Amazon, attempt, Billion, blackout, blend, blind, burn, candidate, canine, cannabinoid, cautiously, CFO, closure, Colorado, commercialize, conversion, credibility, credible, cut, debt, demonstrated, disciplined, double, drawdown, encouraged, exact, exciting, Expert, fall, feedback, fine, fixated, flat, fluctuate, foreseeable, formation, Foundation, fractional, gait, gummy, half, healthy, hereof, highest, immunity, inflammation, infrastructure, Keystone, larger, lifetime, low, mobility, optimistic, patented, pilot, placebo, preliminary, proprietary, ramping, randomized, refinement, regional, rounded, rounding, Sanitation, split, study, sublet, tp, tune, unique, veterinary, WADA, World

Removed: absorption, ADRA, aging, announced, begun, culture, delisted, devote, disappointed, discounted, discrete, effectively, eliminate, employment, greater, improving, indirect, Isodiol, lowering, navigating, noted, pandemic, promote, rationalization, regularly, resurgence, separated, separately, streamline, strength, superior, TSX, velocity, worked, WS

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Associated YCBD transcripts

YCBD similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

Section 1350 Certification

In connection with the Quarterly Report of cbdMD, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2023 as filed with the Securities and Exchange Commission (the “Report”), I, T. Ronan Kennedy, principal executive officer and Chief Financial Officer, of the Company, do hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes- Oxley Act of 2002, that:

1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

2.	The information contained in the Report fairly presents, in all material respects, the financial conditions and results of operations of the Company.

May 15, 2023		/s/ T. Ronan Kennedy
		T. Ronan Kennedy,
		Interim CEO, principal executive officer

May 15, 2023		/s/ T. Ronan Kennedy
		T. Ronan Kennedy,
		Chief Financial Officer,
		principal financial and accounting officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.